Christopher Goss is a Respiratory physician affiliated with Center for Infectious Disease Research. OpenAlex indexes 386 publications with 16,065 citations (h-index 64); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Washington Medical Ctr
1959 NE Pacific St
Seattle, WA 981956166
Telephone
206-598-4615Registry record last updated 6 Sept 2012.
Clinical trials
- A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)
Sponsor: University of Washington
- Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Sponsor: University of Washington
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20253 payments
- Mylan Specialty L.P.Program year20241 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
67.2%Other respiratory system products41.5%Trikafta100%Part D≥16 patientsCorticosteroid13.4%Dulera53%Fluticasone Propionate48%Part D<11 patients+ 1 more class in this area
Anti-infectives
15.4%Macrolide Antimicrobial15.4%Azithromycin100%Part D≥12 patientsMetabolism & gastrointestinal
9.7%Antidiarrheal microorganisms6%Zenpep100%Part D<11 patientsCorticosteroid3.7%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2003–2026 per NIH RePORTER. The latest:
- Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era
Seattle Children'S Hospital
FY2026$1,272,697P30DK089507 - A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).
Seattle Children'S Hospital
FY2026$762,029R01FD006848
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment
American Journal of Respiratory and Critical Care Medicine
2021 - A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
Journal of Cystic Fibrosis
2020 - Acute Pulmonary Exacerbations in Cystic Fibrosis
Seminars in Respiratory and Critical Care Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Wilfond, MD
Center for Infectious Disease Research
Rebecca Gardner, MD
Center for Infectious Disease Research
Lisa Frenkel
Center for Infectious Disease Research
Yongdong Zhao, MD
Center for Infectious Disease Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”